Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2008

Open Access 01-12-2008 | Research article

Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits

Authors: Adit A Ginde, Phillip G Blanc, Rebecca M Lieberman, Carlos A Camargo Jr

Published in: BMC Endocrine Disorders | Issue 1/2008

Login to get access

Abstract

Background

Accurate identification of hypoglycemia cases by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes will help to describe epidemiology, monitor trends, and propose interventions for this important complication in patients with diabetes. Prior hypoglycemia studies utilized incomplete search strategies and may be methodologically flawed. We sought to validate a new ICD-9-CM coding algorithm for accurate identification of hypoglycemia visits.

Methods

This was a multicenter, retrospective cohort study using a structured medical record review at three academic emergency departments from July 1, 2005 to June 30, 2006. We prospectively derived a coding algorithm to identify hypoglycemia visits using ICD-9-CM codes (250.3, 250.8, 251.0, 251.1, 251.2, 270.3, 775.0, 775.6, and 962.3). We confirmed hypoglycemia cases by chart review identified by candidate ICD-9-CM codes during the study period. The case definition for hypoglycemia was documented blood glucose 3.9 mmol/l or emergency physician charted diagnosis of hypoglycemia. We evaluated individual components and calculated the positive predictive value.

Results

We reviewed 636 charts identified by the candidate ICD-9-CM codes and confirmed 436 (64%) cases of hypoglycemia by chart review. Diabetes with other specified manifestations (250.8), often excluded in prior hypoglycemia analyses, identified 83% of hypoglycemia visits, and unspecified hypoglycemia (251.2) identified 13% of hypoglycemia visits. The absence of any predetermined co-diagnosis codes improved the positive predictive value of code 250.8 from 62% to 92%, while excluding only 10 (2%) true hypoglycemia visits. Although prior analyses included only the first-listed ICD-9 code, more than one-quarter of identified hypoglycemia visits were outside this primary diagnosis field. Overall, the proposed algorithm had 89% positive predictive value (95% confidence interval, 86–92) for detecting hypoglycemia visits.

Conclusion

The proposed algorithm improves on prior strategies to identify hypoglycemia visits in administrative data sets and will enhance the ability to study the epidemiology and design interventions for this important complication of diabetes care.
Appendix
Available only for authorised users
Literature
1.
go back to reference The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056/NEJM199309303291401.CrossRef The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056/NEJM199309303291401.CrossRef
2.
go back to reference The United Kingdom Prospective Diabetes Study Research Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998, 352: 837-853. 10.1016/S0140-6736(05)61359-1.CrossRef The United Kingdom Prospective Diabetes Study Research Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998, 352: 837-853. 10.1016/S0140-6736(05)61359-1.CrossRef
3.
go back to reference The United Kingdom Prospective Diabetes Study Research Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet. 1998, 352: 854-865. 10.1016/S0140-6736(05)61359-1.CrossRef The United Kingdom Prospective Diabetes Study Research Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet. 1998, 352: 854-865. 10.1016/S0140-6736(05)61359-1.CrossRef
4.
go back to reference Cryer PE: Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002, 45: 937-948. 10.1007/s00125-002-0822-9.CrossRefPubMed Cryer PE: Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002, 45: 937-948. 10.1007/s00125-002-0822-9.CrossRefPubMed
5.
go back to reference MacLeod KM, Hepburn DA, Frier BM: Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diabet Med. 1993, 10: 238-245.CrossRefPubMed MacLeod KM, Hepburn DA, Frier BM: Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diabet Med. 1993, 10: 238-245.CrossRefPubMed
6.
go back to reference Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study II. Cause-specific mortality inpatients with insulin-treated diabetes mellitus. Diabet Med. 1999, 16: 466-471. 10.1046/j.1464-5491.1999.00076.x.CrossRefPubMed Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study II. Cause-specific mortality inpatients with insulin-treated diabetes mellitus. Diabet Med. 1999, 16: 466-471. 10.1046/j.1464-5491.1999.00076.x.CrossRefPubMed
7.
go back to reference DCCT Research Group: Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997, 46: 271-286. 10.2337/diabetes.46.2.271.CrossRef DCCT Research Group: Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997, 46: 271-286. 10.2337/diabetes.46.2.271.CrossRef
8.
go back to reference Holstein A, Plaschke A, Egberts EH: Incidence and costs of severe hypoglycemia. Diabetes Care. 2002, 25: 2109-10.2337/diacare.25.11.2109.CrossRefPubMed Holstein A, Plaschke A, Egberts EH: Incidence and costs of severe hypoglycemia. Diabetes Care. 2002, 25: 2109-10.2337/diacare.25.11.2109.CrossRefPubMed
9.
go back to reference The International Classification of Diseases, 9th revision. Clinical Modification. 1997, Salt Lake City, UT, Medicode Publications, 5 The International Classification of Diseases, 9th revision. Clinical Modification. 1997, Salt Lake City, UT, Medicode Publications, 5
10.
go back to reference Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R: Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002, 55: 253-259. 10.1016/S0895-4356(01)00479-6.CrossRefPubMed Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R: Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002, 55: 253-259. 10.1016/S0895-4356(01)00479-6.CrossRefPubMed
11.
go back to reference Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997, 15: 1681-1687. 10.1001/archinte.157.15.1681.CrossRef Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997, 15: 1681-1687. 10.1001/archinte.157.15.1681.CrossRef
12.
go back to reference Herings RMC, de Boer A, Stricker BHCh, Leufkens HGM, Porsuis A: Hypoglycemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995, 345: 1195-1198. 10.1016/S0140-6736(95)91988-0.CrossRefPubMed Herings RMC, de Boer A, Stricker BHCh, Leufkens HGM, Porsuis A: Hypoglycemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995, 345: 1195-1198. 10.1016/S0140-6736(95)91988-0.CrossRefPubMed
13.
go back to reference Morris AD, Boyle DIR, McMahon AD, Pearce H, Evans JM, Newton RW, Jung RT, MacDonald TM: ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care. 1997, 20: 1363-1367. 10.2337/diacare.20.9.1363.CrossRefPubMed Morris AD, Boyle DIR, McMahon AD, Pearce H, Evans JM, Newton RW, Jung RT, MacDonald TM: ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care. 1997, 20: 1363-1367. 10.2337/diacare.20.9.1363.CrossRefPubMed
14.
go back to reference Shorr RI, Ray WA, Daugherty JR, Griffin MR: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997, 278: 40-43. 10.1001/jama.278.1.40.CrossRefPubMed Shorr RI, Ray WA, Daugherty JR, Griffin MR: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997, 278: 40-43. 10.1001/jama.278.1.40.CrossRefPubMed
16.
go back to reference American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005, 28: 1245-1249. 10.2337/diacare.28.5.1245.CrossRef American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005, 28: 1245-1249. 10.2337/diacare.28.5.1245.CrossRef
17.
go back to reference Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care. 2003, 26: 1902-1912. 10.2337/diacare.26.6.1902.CrossRefPubMed Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care. 2003, 26: 1902-1912. 10.2337/diacare.26.6.1902.CrossRefPubMed
18.
go back to reference O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM: Measuring diagnoses: ICD code accuracy. HSR. 2005, 40: 1620-1639.PubMedPubMedCentral O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM: Measuring diagnoses: ICD code accuracy. HSR. 2005, 40: 1620-1639.PubMedPubMedCentral
19.
go back to reference Lopushinsky SR, Covarrubia KA, Rabeneck L, Austin PC, Urbach DR: Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endo. 2007, 21 (10): 1733-1737. 10.1007/s00464-006-9136-1.CrossRef Lopushinsky SR, Covarrubia KA, Rabeneck L, Austin PC, Urbach DR: Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endo. 2007, 21 (10): 1733-1737. 10.1007/s00464-006-9136-1.CrossRef
20.
go back to reference Scheurer DB, Hicks LS, Cood EF, Schnipper JL: Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007, 135: 1010-1013. 10.1017/S0950268806007655.CrossRefPubMed Scheurer DB, Hicks LS, Cood EF, Schnipper JL: Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007, 135: 1010-1013. 10.1017/S0950268806007655.CrossRefPubMed
21.
go back to reference Goldstein JB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998, 29: 1602-1604.CrossRefPubMed Goldstein JB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998, 29: 1602-1604.CrossRefPubMed
22.
go back to reference Buchbinder R, Goel V, Bombardier C: Lack of concordance between the ICD-9 classification of soft tissue disorders of the neck and upper limbs and chart review diagnosis: One steel mill's experience. Am J Ind Med. 1996, 29: 171-182. 10.1002/(SICI)1097-0274(199602)29:2<171::AID-AJIM7>3.0.CO;2-V.CrossRefPubMed Buchbinder R, Goel V, Bombardier C: Lack of concordance between the ICD-9 classification of soft tissue disorders of the neck and upper limbs and chart review diagnosis: One steel mill's experience. Am J Ind Med. 1996, 29: 171-182. 10.1002/(SICI)1097-0274(199602)29:2<171::AID-AJIM7>3.0.CO;2-V.CrossRefPubMed
23.
go back to reference Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM, Breiman RF: Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol. 1999, 149: 282-289.CrossRefPubMed Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM, Breiman RF: Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol. 1999, 149: 282-289.CrossRefPubMed
24.
go back to reference Bazarian JJ, Veazie P, Mookerjee S, Lerner EB: Accuracy of Mild Traumatic Brain Injury Case Ascertainment Using ICD-9-CM Codes. Acad Emerg Med. 2006, 13: 31-38. 10.1111/j.1553-2712.2006.tb00981.x.CrossRefPubMed Bazarian JJ, Veazie P, Mookerjee S, Lerner EB: Accuracy of Mild Traumatic Brain Injury Case Ascertainment Using ICD-9-CM Codes. Acad Emerg Med. 2006, 13: 31-38. 10.1111/j.1553-2712.2006.tb00981.x.CrossRefPubMed
25.
go back to reference White RH, Brickner LA, Scannell KA: ICD-9-CM codes poorly identified venous thromboembolism during pregnancy. J Clin Epidemiol. 2004, 57: 985-988. 10.1016/j.jclinepi.2004.02.003.CrossRefPubMed White RH, Brickner LA, Scannell KA: ICD-9-CM codes poorly identified venous thromboembolism during pregnancy. J Clin Epidemiol. 2004, 57: 985-988. 10.1016/j.jclinepi.2004.02.003.CrossRefPubMed
Metadata
Title
Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Authors
Adit A Ginde
Phillip G Blanc
Rebecca M Lieberman
Carlos A Camargo Jr
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2008
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-8-4

Other articles of this Issue 1/2008

BMC Endocrine Disorders 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.